| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C0013178> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C0282461> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/33807839_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Biomedical and Molecular Sciences, Queen\'s University, Kingston, ON K7L 3N6, Canada.\', \'Scientific Research Division, Novateur Ventures Inc., Vancouver, BC V6E 3P3, Canada.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Ardakani_Ali> <https://research.tib.eu/covid-19/entity/Funk_Colin_D> <https://research.tib.eu/covid-19/entity/Laferri%C3%A8re_Craig>
?:doi	41810.3390/v13030418
?:doi	<https://research.tib.eu/covid-19/entity/41810.3390/v13030418>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Viruses
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33807839>
?:pmid	<https://research.tib.eu/covid-19/entity/33807839>
?:pmid	33807839
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.805
?:rankingScore_hIndex	52
?:title	Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33807839>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33807839>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all